α1-Antitrypsin blocks the release of transforming growth factor-α from MCF-7 human breast cancer cells

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 3, 1997, Pages 745-752

  Yavelow, Jonathan ^a   Tuccillo, Anna ^a,c   Kadner, Susan S ^b   Katz, Joseph ^b   Finlay, Thomas H ^b  

^a RIDER UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELASTASE; ESTRADIOL; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEINASE; STROMELYSIN; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; ESTROGEN RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEINASE INHIBITION;

ALPHA 1-ANTITRYPSIN; BREAST NEOPLASMS; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPEPTIDASES; ESTRADIOL; FEMALE; HUMANS; SOLUBILITY; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED;

EID: 0031042878     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.3.745     Document Type: Article

References (42)

1. Lee DC, Fenton SE, Berkowitz EA, Hissong MA. 1995 Transforming growth factor α: expression, regulation, and biological activities. Pharm Rev. 47:51-85.
2. Massagué J, Pandiella A. 1993 Membrane-anchored growth factors. Annu Rev Biochem. 62:515-541.
3. Teixido J, Wong ST, Lee DC, Massagué J. 1990 Generation of transforming growth factor-α from the cell surface by an O-glycosylation-independent multistep process. J Biol Chem. 265:6410-6415.
4. Anklesaria P, Texido J, Laiho M, Pierce JH, Greenberger JS, Massagué J. 1990 Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor α to epidermal growth factor receptors promotes cell proliferation. Proc Natl Acad Sci USA. 87:3289-3293.
5. Lindberg I. 1991 The new eukaryotic precursor processing proteinases. Mol Endocrinol. 5:1361-1365.
6. Ehlers MRW, Riordan JF. 1991 Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. Biochemistry. 30:10065-10074.
7. Torres-Rosado A, O'Shea KS, Tsuji A, Arai T, Chou S-H, Kurachi K. 1993 Hepsin, a putative cell-surface serine protease is required for mammalian cell growth. Proc Natl Acad Sci USA. 90:7181-7185.
8. Potempa J, Korzus E, Travis J. 1994 The serpin superfamily of proteinase inhibitors: structure, function and regulation. J Biol Chem. 269:15957-15960.
9. Rice WG, Weiss SJ. 1990 Regulation of proteolysis at the neutophil-substrate interface by secretory leukoprotease inhibitor. Science. 249:178-181.
10. Pandiella A, Bosenberg MW, Huang EJ, Besmer P, Massagué J. 1992 Cleavage of membrane-anchored growth factors involves distinct protease activities regulated through common mechanisms. J Biol Chem. 267:24028-24033.
11. Cappelluti E, Strom SC, Harris RB. 1993 Potential role of two novel elastase-like enzymes in processing pro-transforming growth factor-α. Biochemistry. 32:551-560.
12. Harris JR, Lippman ME, Veronesi UV, Willett W. 1992 Breast cancer. N Engl J Med. 327:319-328, 390-398, 473-480.
13. Bates SE, Davidson NE, Valverius EM. 1988 Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol. 2:543-555.
14. Manni A, Wright C, Buck H. 1991 Growth factor involvement in the multi-hormonal regulation of MCF-7 breast cancer growth in soft agar. Breast Cancer Res Treat. 20:43-52.
15. Castelliani R, Visscher DW, Wykes S, Sarkar FH, Crissman JD. 1994 Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast carcinoma. Cancer. 73:344-349.
16. McGilligan KM, Thomas DW, Eckert CD. 1987 Alpha-1-antitrypsin concentration in human milk. Pediatr Res. 22:268-270.
17. 1-proteinase inhibitor gene in human monocytes and macrophages. Proc Natl Acad Sci USA. 82:795-799.
18. Tamir S, Kadner SS, Katz J, Finlay TH. 1990 Regulation of antitrypsin and antichymotrypsin synthesis by MCF-7 breast cancer cell lines. Endocrinology. 127:1319-1328.
19. 1-Antitrypsin and anchorage-independent growth of MCF-7 breast cancer cells. Endocrinology. 133:996-1002.
20. Finlay TH, Kadner SS, Tamir S. 1993 Protease inhibitor synthesis by MCF-7 breast cancer cells. In: Troll W, Kennedy A, eds. Protease inhibitors as cancer chemopreventative agents. New York: Plenum Press; 141-159.
21. 1-antitrypsin by human trophoblast cells. Pediatr. Res. 34:312-317.
22. Chirgwin JM, Pryzbyla AE, McDonald RJ, Rutter WJ. 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
23. Sambrook J, Fritsch EF, Maniatis T. 1989 Molecular cloning-a laboratory manual, 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory.
24. Freedman VH, Shin S. 1974 Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid media. Cell. 3:355-359.
25. 1-antitrypsin-protease complexes is mediated by the serpin-enzyme complex (SEC) receptor. J Biol Chem. 265:16713-16716.
26. Billings PC, Habres JM. 1992 A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor. Proc Natl Acad Sci USA. 89:3120-3124.
27. Crystal RG. 1990 α1-Antitrypsin deficiency, emphysema, and liver disease: genetic basis and strategies for therapy. J Clin Invest. 85:1343-1352.
28. Zou Z, Anisowicz A, Hendrix MJC, et al. 1994 Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 263:526-529.
29. Pemberton PA, Wong DT, Gibson HL, et al. 1995 The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases: evidence that maspin is not a protease inhibitor. J Biol Chem. 270:15832-15837.
30. Baselga J, Mendelsohn J, Kim Y-M, Pandiella A. 1996 Autocrine regulation of membrane transforming growth factor-α cleavage. J Biol Chem. 271:3279-3284.
31. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. 1990 Increased cell division as a cause of human cancer. Cancer Res. 50:7415-7421.
32. Lippman ME, Dickson RB. 1989 Growth control of normal and malignant breast epithelium. Proc R Soc Edinburgh. 95B:89-106.
33. Lamson G, Giudice LC, Cohen P, et al. 1993 Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo. Growth Regul. 3:91-95.
34. Majumdar MK, Feng L, Medlock E, Toksoz D, Wiliams DA. 1994 Identification and mutation of primary and secondary proteolytic cleavage sites in murine stem cell factor cDNA yields biologically active, cell-associated protein. J Biol Chem. 269:1237-1242.
35. Jue D-M, Sherry B, Luedke C, Manogue KR, Cerami A. 1990 Processing of newly synthesized cachetin/tumor necrosis factor in endotoxin-stimulated macrophages. Biochemistry. 29:8371-8377.
36. Arribas J, Massagué J. 1995 Transforming growth factor-α and β-amyloid precursor protein share a secretory mechanism. J Cell Biol. 128:433-441.
37. Harano T, Mizuno K. 1994 Phorbol ester-induced activation of a membrane-bound candidate pro-transforming growth factor-α processing enzyme. J Biol Chem. 269:20305-20311.
38. Zhang M, Zou Z, Maass N, Sager R. 1995 Differential expression of elafin in normal mammary epithelial cells and carcinomas is regulated at the transcriptional level. Cancer Res. 55:2537-2541.
39. Basset P, Wolf C, Chambon P. 1993 Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review. Breast Cancer Res Treat. 24:185-193.
40. Pei D, Majmudar G, Weiss SJ. 1994 Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem. 269:25849-25855.
41. Pei D, Weiss SJ. 1995 Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature. 375:244-247.
42. Schagger H, von Jagow G. 1987 Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 111:368-379.